Skip to content

Contact +44 (0) 20 7060 7474 email us

Diagnostics

Diagnostics Market Research, Intelligence and Forecasts

In this section you will find information products, including market research, regarding diagnostics market, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.

Stay up-to-date with new products added to this category »
Title Publication Date Price
Molecular Diagnostics
Technologies, Markets and Companies
March 2010 £3300
The Future of The in-Vitro Diagnostics Market to 2016
Increasing Diagnostic Procedures Drive Demand
January 2010 £2310
Chinese Markets for In Vitro Diagnostics
January 2010 £2640
Molecular Diagnostics in Cancer Testing
December 2009 £2245
Point of Care Diagnostics
December 2009 £3205
Point of Care Diagnostics: Players, Products & Future Market Prospects
November 2009 £995
DNA Probes-Based Diagnostics
A Worldwide Market Review
November 2009 £1980
Peptic Ulcer Testing
A World Market Intelligence Report
November 2009 £1980
Genetic Testing
A Global Update of Market Trends & Opportunities
November 2009 £1980
Molecular Diagnostics
A World Market Review
November 2009 £1980
UK Diagnostic Imaging Market Analysis and Forecasts to 2015
September 2009 £2310
Competitor Analysis VEGF and VEGF-R Agonists and Antagonists
September 2009 £540
Advanced Digital Diagnostic Medical Imaging Equipment Market Analysis & Directions
September 2009 £1515
U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions
Market Trends, New Product Trends, Technology Trends, Distribution Structure and 15 Notable Company Case Studies
September 2009 £1850
Over-the-Counter Diagnostic Products World Markets
August 2009 £2245
Global Molecular Diagnostics Market
Opportunities & Future Forecast
August 2009 £660
Infectious Disease Diagnostic Markets
August 2009 £2310
Coagulation Factors 2009
Target Pipeline and Corporate Benchmark Analysis
August 2009 £2195
Medical Ultrasound Systems Market Worldwide. 2009
July 2009 £1650
Strategic Analysis of U.S. Drugs of Abuse Laboratory Testing
July 2009 £3965
The Top 40 Manufacturers Of Diagnostic Imaging Equipment In Europe
June 2009 £250
Point of Care Diagnostic Testing Sector Trends
June 2009 £2245
The Top 100 Point-Of-Care Manufacturing Companies Worldwide
Second Edition
May 2009 £625
HIV Qualitative NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Viral Load NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Qualitative NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Genotyping NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Viral Load NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Viral Load NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Viral Load NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Viral Load NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Genotyping NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Genotyping NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Qualitative NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Qualitative NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Genotyping NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Genotyping NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Qualitative NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Viral Load NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Genotyping NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Genotyping NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Genotyping NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Genotyping NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Genotyping NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Quantitative NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Quantitative NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HLA Typing NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HLA Typing NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Viral Load NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Viral Load NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Viral Load NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HLA Typing NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HLA Typing NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HLA Typing NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HIV Viral Load NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Genotyping NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group B Streptococcus (GBS) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group B Streptococcus (GBS) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group A Streptococcus (GAS) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group A Streptococcus (GAS) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group B Streptococcus (GBS) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group B Streptococcus (GBS) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Quantitative NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Quantitative NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group B Streptococcus (GBS) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group A Streptococcus (GAS) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group A Streptococcus (GAS) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Fragile X NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Factor V Leiden NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Factor V Leiden NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Factor V Leiden NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Fragile X NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Fragile X NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Group A Streptococcus (GAS) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Fragile X NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Fragile X NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Quantitative NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Quantitative NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Quantitative NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Genotyping NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Genotyping NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Genotyping NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Genotyping NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Qualitative NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Qualitative NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Qualitative NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Qualitative NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Viral Load NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Viral Load NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Ressistance NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Ressistance NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Ressistance NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Quantitative NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Ressistance NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Ressistance NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Viral Load NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Viral Load NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HBV Viral Load NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HCV Qualitative NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 1 NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Parainfluenza 1, 2, 3 NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Parainfluenza 1, 2, 3 NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Parainfluenza 1, 2, 3 NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Neisseria Gonorrheae (NG) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Parainfluenza 1, 2, 3 NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Parainfluenza 1, 2, 3 NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
RSV NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
RSV NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
RSV NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Neisseria Gonorrheae (NG) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Neisseria Gonorrheae (NG) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium tuberculosis (MTB) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium tuberculosis (MTB) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium Tuberculosis Direct (MTD) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium Tuberculosis Direct (MTD) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium tuberculosis (MTB) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium tuberculosis (MTB) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Neisseria Gonorrheae (NG) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Neisseria Gonorrheae (NG) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium tuberculosis (MTB) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
RSV NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
RSV NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
VZV NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
VZV NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
VZV NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
VZV NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
VZV NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
VRE NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Staphylococcus aureus NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Staphylococcus aureus NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Staphylococcus aureus NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Staphylococcus aureus NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Staphylococcus aureus NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
VRE NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
VRE NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
VRE NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
VRE NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium Tuberculosis Direct (MTD) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium Tuberculosis Direct (MTD) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Her2Neu NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Her2Neu NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Her2Neu NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Her2Neu NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Her2Neu NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Human Metapneumovirus (hMPV) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Human Metapneumovirus (hMPV) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Human Metapneumovirus (hMPV) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Human Metapneumovirus (hMPV) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 2 NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 2 NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 1 NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 1 NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 1 NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Quantitative NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Factor V Leiden NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 1 NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 2 NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 2 NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
HSV 2 NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Human Metapneumovirus (hMPV) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Influenca A/B NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
MSSA NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
MRSA NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
MRSA NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
MRSA NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
MSSA NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
MSSA NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Mycobacterium Tuberculosis Direct (MTD) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
MSSA NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
MSSA NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
MRSA NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
MRSA NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Influenca A/B NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Influenca A/B NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Influenca A/B NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Influenca A/B NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
MAC NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
MAC NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
MAC NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
MAC NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
MAC NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
HPV Quantitative NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Epstein-Barr Virus (EBV) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMF Viral Load NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMF Viral Load NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMF Viral Load NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
BK Virus NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
BK Virus NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
BK Virus NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
BK Virus NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMF Viral Load NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMF Viral Load NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Chlamydia Trachomatis (CT) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Chlamydia Trachomatis (CT) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMV Quant NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMV Quant NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMV Quant NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMV Quant NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
BK Virus NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Assessment of the Molecular Diagnostic Market for Adenovirus NA Tests in Germany
April 2009 £360
Technology Trends and Business Opportunities in Latin American X-Ray Market
April 2009 £3965
Adenovirus NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Diagnostics & Pathology in India
April 2009 £600
Medical Diagnostics - India
April 2009 £230
Diagnostic & Medical Laboratories in the US
IBISWorld Industry Report
April 2009 £430
Factor V Leiden NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Adenovirus NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Adenovirus NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Assessment of the Molecular Diagnostic Market for 44 NA Tests in Spain
April 2009 £8065
Assessment of the Molecular Diagnostic Market for 44 NA Tests in UK
April 2009 £8065
Assessment of the Molecular Diagnostic Market for 44 NA Tests in Italy
April 2009 £8065
Assessment of the Molecular Diagnostic Market for 44 NA Tests in Germany
April 2009 £8065
Adenovirus NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Assessment of the Molecular Diagnostic Market for 44 NA Tests in France
April 2009 £8065
Chlamydia Trachomatis (CT) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
CMV Quant NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Chlamydia Trachomatis (CT) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Enterovirus NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Epstein-Barr Virus (EBV) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Enterovirus NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Enterovirus NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Cystic Fibrosis, Mucoviscoidosis NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Enterovirus NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Epstein-Barr Virus (EBV) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Epstein-Barr Virus (EBV) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Factor II NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Factor II NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Factor II NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Factor II NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Epstein-Barr Virus (EBV) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Factor II NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Cystic Fibrosis, Mucoviscoidosis NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Enterovirus NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Chlamydia Trachomatis (CT) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Cystic Fibrosis, Mucoviscoidosis NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Clostridium Difficile (C.diff) NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Clostridium Difficile (C.diff) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Cystic Fibrosis, Mucoviscoidosis NA Tests in Germany
Assessment of the Molecular Diagnostic Market
April 2009 £360
Clostridium Difficile (C.diff) NA Tests in UK
Assessment of the Molecular Diagnostic Market
April 2009 £360
Cystic Fibrosis, Mucoviscoidosis NA Tests in France
Assessment of the Molecular Diagnostic Market
April 2009 £360
Clostridium Difficile (C.diff) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
April 2009 £360
Clostridium Difficile (C.diff) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
April 2009 £360
In-Vitro Diagnostics
US Industry Study with Forecasts for 2013 & 2018
March 2009 £3170
InvestFrost Healthcare - European Ophthalmic Surgical Devices Market Outlook
March 2009 £3965
Top Ten Global In-Vitro Diagnostics Companies
Positioning, performance and SWOT analyses
March 2009 £2025
The Top 100 Molecular Diagnostics Manufacturing Companies Worldwide
March 2009 £625
World Market for Molecular Diagnostics, The
January 2009 £2640
Molecular Diagnostics
A Dynamic and Rapidly Broadening Market Overview
January 2009 £2475
Molecular Diagnostics: a primer on an emerging sector
November 2008 £2640
High-Growth Diagnostic Testing Markets
November 2008 £2245
HighGrowth Diagnostic Markets
November 2008 £2245
Molecular Diagnostics Markets
September 2008 £2245
Point of Care Diagnostic Testing World Markets
September 2008 £2245
Women's Health: Diagnostic Testing
August 2008 £1200
Commercializing Molecular Diagnostics:
Products, Services, Companies and Global Market
July 2008 £1715
In Vitro Diagnostics Market Report & Analysis 2008-2023
June 2008 £1499
Companion Diagnostics Markets
(A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine)
June 2008 £1980
B·R·A·H·M·S Aktiengesellschaft Product Pipeline Analysis
May 2008 £495
Genomics World Markets
May 2008 £2245
The Worldwide Market for In Vitro Diagnostic Tests
6th Edition [with 2009 Economy Preface]
May 2008 £2640
Epigenetics and MicroRNA Diagnostics/Therapeutics 2008
May 2008 £2350
Multiplexed Diagnostics 2008
May 2008 £2350
Convergence of Biomarkers and Diagnostics, The
Therapy Area Analyses, Key Products and Future Trends
April 2008 £1995
Diagnostics & Pathology Laboratories
April 2008 £600
Blood Banking and Blood products
March 2008 £2610
Molecular Diagnostics in China
February 2008 £2640
Clinical Diagnostics in China
Market Sector Analyses and Participant Directory
January 2008 £6865
U.S.DNA-Based Diagnostic and Test Market
January 2008 £1850
DNA Diagnostics: Technologies and Global Markets
January 2008 £3205
Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies
January 2008 £110
The Decentralized Diagnostic Testing Markets Business Challenges And Marketing Strategies
January 2008 £13075
Three Alternative Scenarios Of The Future In Vitro Diagnostics Market 2007-2016
January 2008 £7795
Nanotechnology
Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics
January 2008 £1995
In Vitro Diagnostics
Development through Postmarket
January 2008 £2175
The World Orthopaedic Market Report 2008
December 2007 £995
Diagnosis of Fungal Infections
December 2007 £115
Textbook of Men's Health and Aging
December 2007 £0
The Endometrium: Molecular, Cellular and Clinical Perspectives
2nd edition
December 2007 £280
Encephalitis: Diagnosis and Treatment
December 2007 £115
Diagnostic Ultrasound
November 2007 £315
Cell-Based Diagnostics: Technology, Applications, and Markets
2nd Edition
November 2007 £2640
Mayo Clinic Cardiology: Board Review Questions and Answers
November 2007 £115
Clinical Diagnosis and Management of Dystonia
November 2007 £75
Dispense & Imaging Trends 2007
November 2007 £1540
Myeloproliferative Disorders: Biology and Management
October 2007 £105
Medical Imaging
Equipment And Related Products
October 2007 £3205
Anaerobic Infections: Diagnosis and Management
September 2007 £115
Physiological Basis of Aging and Geriatrics
4th edition
September 2007 £85
Functional Neuroradiology
September 2007 £145
Advances in Nuclear Oncology: Diagnosis and Therapy
September 2007 £215
Clinical Handbook of Pediatric Infectious Disease
September 2007 £95
Mayo Clinic Internal Medicine Concise Textbook
September 2007 £55
Handbook of Sleep Disorders, 2nd
September 2007 £145
Market Status and Forecast on Chinese Diagnostic Imaging Equipment Market
August 2007 £230
Atlas of Cardiometabolic Risk
August 2007 £55
Garner and Klintworth's Pathobiology of Ocular Disease, 3rd edition
August 2007 £0
Clinical Diagnosis and Management of Dystonia
August 2007 £75
Dermal Absorption and Toxicity Assessment
August 2007 £130
Diagnosis of Fungal Infections
August 2007 £115
Managing Antimicrobial Resistance
August 2007 £115
Pediatric Retina
August 2007 £145
The Diagnostic Equipment Service Conundrum
How Much Is Too Much? How Little Is Too Little?
July 2007 £1320
Head and Neck Manifestations of Systemic Disease
July 2007 £170
China's In Vitro Diagnostic Testing Industry
Sector Snapshot
June 2007 £330
Early Toxicology
Markets and Approaches
June 2007 £2310
Advances in Nuclear Oncology
Diagnosis and Therapy
June 2007 £140
Valvular Heart Disease
Pathologic, Echocardiographic and Surgical Correlations
June 2007 £135
Fractures of the Pelvis and Acetabulum
June 2007 £110
Myocardial Perfusion Scintigraphy: From Request to Report
June 2007 £125
Myocardial Perfusion Scintigraphy: From Request to Report
June 2007 £105
The Aorta: Structure, Function, Dysfunction and Diseases
June 2007 £125
Antimicrobial Pharmacodynamics in Theory and Clinical Practice, 2nd Edition
June 2007 £110
Molecular Diagnostics 2007
Technologies, Companies, Products, Applications and Worldwide Outlook
May 2007 £1515
Atlas of Intracytoplasmic Sperm Injection
May 2007 £75
Neurogenetics of Psychiatric Disorders
May 2007 £100
Obstructive Sleep Apnea
Diagnosis and Treatment
May 2007 £145
Chronic Rhinosinusitis
May 2007 £110
Physician Office Laboratory (POL) Testing Markets Worldwide
Status Quo and Future Trends
May 2007 £2310
In Vitro Diagnostics to 2009
Demand and Sales Forecasts, Market Share, Market Size, Market Leaders
April 2007 £2970
The Vulnerable Plaque, 2nd edition
April 2007 £210
Fever of Unknown Origin
April 2007 £130
Problem-Oriented Approaches in Interventional Cardiology
April 2007 £115
Rickettsial Diseases
April 2007 £130
Medical Immunology, 6th edition
April 2007 £74.99
Echocardiography: A Practical Guide for Reporting
2nd edition
April 2007 £50
Heparin-Induced Thrombocytopenia
4th edition
April 2007 £115
Twin-Twin Transfusion Syndrome
April 2007 £85
The Market for In Vitro Toxicology Testing
March 2007 £3205
Therapeutic/Diagnostic Devices for Neurological Disorders
March 2007 £3205
Molecular Diagnostics
Major World Markets
February 2007 £2640
Lateral Flow Technology and the Future of Point of Care Diagnostics
February 2007 £1980
Medical and Diagnostic Laboratories in the US
IBISWorld Industry Report
January 2007 £430
Complete Guide to the Diagnostic Market 2007-2012
January 2007 £1600
In Vitro Diagnostic Industry Leading Players Comparison and Review
Sector Snapshot
January 2007 £330
Clinical Diagnostics in India
Market Sector Analyses and Participant Directory
December 2006 £3300
Medical Imaging: Reagents and Analysis Tools
December 2006 £2885
Worldwide Point of Care (POC)
Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?
November 2006 £1980
Innovations in Diagnostics
September 2006 £1495
Blood
The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
September 2006 £2575
Point of Care Diagnostics Market in the US:
August 2006 £1870
India's In Vitro Diagnostic Testing Industry
Sector Snapshot
July 2006 £330
Patient Monitoring
April 2006 £2885
Diagnostics and Therapeutics for Genetic Diseases
April 2006 £2885
Market Opportunity Analysis for Point of Care Diagnostic Testing in France, A
March 2005 £2750
The Top 100 In Vitro Diagnostics Manufacturing Companies In Europe
(2nd ed.)
April 2004 £625
Pharmacodiagnostics and Personalized Medicine 2009
(Markets, Challenges, Forecasts and Key Players)
April 2004 £2310
World Markets for Point of Care Diagnostics 2009-13
April 2004 £2180
Who's Doing What in Molecular Diagnostics?
Kalorama / Emmes Survey of US Laboratories
February 2002 £3300